These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review. Iammatteo M; Blumenthal KG; Saff R; Long AA; Banerji A J Allergy Clin Immunol Pract; 2014; 2(6):768-74. PubMed ID: 25439369 [TBL] [Abstract][Full Text] [Related]
6. Allergic drug reactions: from basic research to clinical practice. Blanca M; Thong BY Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):275-8. PubMed ID: 21720219 [No Abstract] [Full Text] [Related]
7. Provocation tests in diagnosing drug hypersensitivity. Bousquet PJ; Gaeta F; Bousquet-Rouanet L; Lefrant JY; Demoly P; Romano A Curr Pharm Des; 2008; 14(27):2792-802. PubMed ID: 18991698 [TBL] [Abstract][Full Text] [Related]
9. A practical method of drug provocation testing to prove tolerance to alternative drugs in drug hypersensitivity. Çelebioğlu E; Öztürk Aktaş Ö; Karakaya G; Kalyoncu AF Turk J Med Sci; 2021 Apr; 51(2):604-609. PubMed ID: 33021762 [TBL] [Abstract][Full Text] [Related]
10. Pro and Contra: Provocation Tests in Drug Hypersensitivity. Soyer O; Sahiner UM; Sekerel BE Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28677662 [TBL] [Abstract][Full Text] [Related]
11. The Value of In Vitro Tests to DiminishDrug Challenges. Mayorga C; Doña I; Perez-Inestrosa E; Fernández TD; Torres MJ Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590437 [TBL] [Abstract][Full Text] [Related]
12. Outcomes and safety of drug provocation tests. Aun MV; Bisaccioni C; Garro LS; Rodrigues AT; Tanno LK; Ensina LF; Kalil J; Motta AA; Giavina-Bianchi P Allergy Asthma Proc; 2011; 32(4):301-6. PubMed ID: 21781406 [TBL] [Abstract][Full Text] [Related]
13. [Drug allergies and drug hypersensitivities]. Demoly P Rev Prat; 2007 Jun; 57(12):1326-30. PubMed ID: 17717945 [TBL] [Abstract][Full Text] [Related]
14. Utility of drug provocation tests in the evaluation of quinolone hypersensitivity reactions. Chiriac AM; Tanno LK; Landry Q; Fillard A; Grylaki M; Lefevre S; Demoly P J Allergy Clin Immunol Pract; 2021 May; 9(5):2097-2100.e2. PubMed ID: 33383193 [No Abstract] [Full Text] [Related]
15. Patch testing for adverse drug reactions. Sekhon S; Nedorost ST Cutis; 2017 Jan; 99(1):49-54. PubMed ID: 28207004 [TBL] [Abstract][Full Text] [Related]
17. Skin tests in the diagnosis of drug hypersensitivity reactions. Brockow K; Romano A Curr Pharm Des; 2008; 14(27):2778-91. PubMed ID: 18991697 [TBL] [Abstract][Full Text] [Related]
18. Spanish Society of Allergology and Clinical Immunology (SEAIC) Vision of Drug Provocation Tests. Audicana MT; Ortega N; Lobera T; Blanca-López N; De la Parte B; García I; Gelis S; Martín J; Barranco R; Vila C; Laguna JJ; J Investig Allergol Clin Immunol; 2021 Oct; 31(5):385-403. PubMed ID: 33653682 [TBL] [Abstract][Full Text] [Related]
19. Drug provocation tests in hypersensitivity drug reactions. Rerkpattanapipat T; Chiriac AM; Demoly P Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):299-304. PubMed ID: 21659856 [TBL] [Abstract][Full Text] [Related]
20. Drug re-challenges in cutaneous adverse drug reactions: information and effectiveness in the long-term management of patients. Waton J; Pouget-Jasson C; Loos-Ayav C; Trechot P; Bursztejn AC; Schmutz JL; Barbaud A Allergy; 2011 Jul; 66(7):941-7. PubMed ID: 21303375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]